Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

SGLT2 Inhibitors May Predispose to Ketoacidosis.

Taylor SI, Blau JE, Rother KI.

J Clin Endocrinol Metab. 2015 Aug;100(8):2849-52. doi: 10.1210/jc.2015-1884. Review.

2.

A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient.

Sanyoura M, Woudstra C, Halaby G, Baz P, Senée V, Guillausseau PJ, Zalloua P, Julier C.

Eur J Hum Genet. 2014 Jan;22(1):140-3. doi: 10.1038/ejhg.2013.87.

3.

Pathogenesis of A⁻β⁺ ketosis-prone diabetes.

Patel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, Iyer D, Nalini R, Ozer K, Hampe CS, Newgard CB, Balasubramanyam A.

Diabetes. 2013 Mar;62(3):912-22. doi: 10.2337/db12-0624.

4.

Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?

Low JC, Felner EI, Muir AB, Brown M, Dorcelet M, Peng L, Umpierrez GE.

Prim Care Diabetes. 2012 Apr;6(1):61-5. doi: 10.1016/j.pcd.2011.11.001.

5.

Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes.

Umpierrez GE, Smiley D, Robalino G, Peng L, Gosmanov AR, Kitabchi AE.

Diabetes Care. 2010 Mar;33(3):626-31. doi: 10.2337/dc09-1369.

6.
Items per page

Supplemental Content

Loading ...
Support Center